← FDA Drug Approvals (Drugs@FDA)

PEMETREXED DISODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 2022-05-25

Drug application

FDA Application #

ANDA202111

Application type

Abbreviated New Drug Application (Generic)

Brand name

PEMETREXED DISODIUM

Generic name

MEXILETINE HYDROCHLORIDE

Active ingredients

PEMETREXED DISODIUM

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

HOSPIRA

Manufacturer

Senores Pharmaceuticals, Inc.

First approval

2022-05-25

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown